Loading market dashboard
The Oncology Institute, Inc.
TOIHealthcareNASDAQUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
TORONTO, May 31, 2026 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV: TOI), acting through its subsidiary TSS Europe B.V. (“TSS”), today submitted a revised non-binding indicative proposal to acquire ReadyTech Holdings Limited (ASX: RDY) (“ReadyTech”) by way of a scheme of arrangement for cash consideration of $2.00 per share (the “Scheme Consideration”), or in the alternative, an off-market takeover bid with a 50.1% minimum acceptance condition at a cash consideration of $1.75 per share (the "Takeover Consideration") (together, the "Revised Proposal")1. All references herein to currency are in Australian dollars.
CERRITOS, Calif., May 26, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Yale D.
Topicus.com Inc. (TOI:CA) Shareholder/Analyst Call Prepared Remarks Transcript
CERRITOS, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that Dr. Daniel Virnich, Chief Executive Officer, and Rob Carter, Chief Financial Officer, will participate in the B.
TORONTO, May 11, 2026 (GLOBE NEWSWIRE) -- As previously announced on April 10, 2026, the Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Friday, May 15, 2026 at 8:00 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Friday, May 15, 2026 at 8:15 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Friday, May 15, 2026 at 8:30 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person. The Topicus meeting, Lumine meeting, and Constellation meeting will take place in person at Delta Hotels Toronto, 75 Lower Simcoe Street, Toronto, Ontario, M5J 3A6.
Oncology Institute NASDAQ: TOI reported a strong start to 2026, with first-quarter revenue rising 41% year over year as the company expanded value-based care arrangements and posted record specialty pharmacy performance.
The Oncology Institute, Inc. (TOI) came out with a quarterly loss of $0.02 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to a loss of $0.17 per share a year ago.
CERRITOS, Calif., May 07, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its three months ended March 31, 2026.
TORONTO, May 05, 2026 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) in a joint release with Constellation Software Inc. (TSX:CSU) today announced financial results for Topicus.com Inc. (“Topicus” or the “Company”) for the first quarter ended March 31, 2026. Please note that all amounts referred to in this press release are in Euros unless otherwise stated.
CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m.
TORONTO, April 15, 2026 (GLOBE NEWSWIRE) -- Topicus.com Inc. (TSXV:TOI) announced today it intends to release its first quarter results on May 5, 2026.
The Oncology Institute, Inc. (NASDAQ: TOI - Get Free Report) major shareholder Jorey Chernett acquired 20,000 shares of the firm's stock in a transaction on Thursday, April 9th. The shares were bought at an average price of $3.10 per share, for a total transaction of $62,000.00. Following the completion of the transaction, the insider owned 10,499,358
TORONTO, April 10, 2026 (GLOBE NEWSWIRE) -- The Topicus.com Inc. (“Topicus”) (TSXV:TOI) annual general meeting of shareholders will be held on Friday, May 15, 2026 at 8:00 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person. The Lumine Group Inc. (“Lumine Group”) (TSXV:LMN) annual general meeting of shareholders will be held on Friday, May 15, 2026 at 8:15 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person. The Constellation Software Inc. (“Constellation” or “CSI”) (TSX:CSU) annual meeting of shareholders will be held on Friday, May 15, 2026 at 8:30 a.m. ET using a hybrid meeting format with proceedings conducted via live webcast and in person.
The Oncology Institute, Inc. (TOI) Q4 2025 Earnings Call Transcript
CERRITOS, Calif., March 12, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), one of the largest value-based community oncology groups in the United States, today reported financial results for its fourth quarter and year ended December 31, 2025.
